# MATERIALISE NV RESULTATEN VAN DE JAARLIJKSE ALGEMENE AANDEELHOUDERSVERGADERING VAN 16 JUNI 2026
Canonical URL: https://biopharmsignal.com/news/MTLS/materialise-nv-resultaten-van-de-jaarlijkse-algemene-aandeelhoudersvergadering-van-16-juni-2026
Ticker: MTLS
Company: Materialise
Source: Materialise
Published: 2026-06-25 13:46 EST
Original Source URL: https://investors.materialise.com
## Summary

Leuven – 17 juni 2026 – 22:00 CET Gereglementeerde informatie Materialise NL AGM PR 17 juni 2026 – Materialise NV (Euronext: MTLS) (Nasdaq: MTLS) (“ Materialise ”) (de “ Vennootschap ”) maakt hierb

## Article Body
Leuven – 17 juni 2026 – 22:00 CET Gereglementeerde informatie Materialise NL AGM PR 17 juni 2026 – Materialise NV (Euronext: MTLS) (Nasdaq: MTLS) (“ Materialise ”) (de “ Vennootschap ”) maakt hierbij de resultaten bekend van de stemmen uitgebracht tijdens haar jaarlijkse
## Recent Company News
- 2026-07-01 20:05 EST — [Annual General Meeting of Materialise NV held at the registered office of the Company on Tuesday 16 June 2026 at 10:00 (CET): Resolutions](https://biopharmsignal.com/news/MTLS/annual-general-meeting-of-materialise-nv-held-at-the-registered-office-of-the-co-5541f657) — Source: Materialise
- 2026-06-29 20:00 EST — [MATERIALISE SHARE-BUY BACK PROGRAM](https://biopharmsignal.com/news/MTLS/materialise-share-buy-back-program-772511f8) — Source: Materialise
- 2026-06-29 20:00 EST — [MATERIALISE AANDELENINKOOPPROGRAMMA](https://biopharmsignal.com/news/MTLS/materialise-aandeleninkoopprogramma-deec859b) — Source: Materialise
- 2026-06-25 13:46 EST — [MATERIALISE NV RESULTATEN VAN DE JAARLIJKSE ALGEMENE AANDEELHOUDERSVERGADERING VAN 16 JUNI 2026](https://biopharmsignal.com/news/MTLS/materialise-nv-resultaten-van-de-jaarlijkse-algemene-aandeelhoudersvergadering-van-16-juni-2026) — Source: Materialise
- 2026-06-25 13:46 EST — [MATERIALISE NV RESULTS OF ANNUAL GENERAL SHAREHOLDERS’ MEETING OF 16 JUNE 2026](https://biopharmsignal.com/news/MTLS/materialise-nv-results-of-annual-general-shareholders-meeting-of-16-june-2026) — Source: Materialise
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)